Literature DB >> 10988221

Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement.

I Maillard1, V Schweizer, A Broccard, A Duscher, L Liaudet, M D Schaller.   

Abstract

Paradoxical vocal cord movement (PVCM) is characterized by paradoxical adduction of the vocal cords during inspiration and/or expiration. Patients with severe forms of PVCM can present with acute dyspnea. In this article, we describe a patient with severe PVCM who had required tracheal intubation or tracheostomy at multiple occasions and who presented with acute hypercapnic respiratory failure. Using sedation and intralaryngeal injection of botulinum toxin type A, we could avoid more invasive intervention. Our observation shows that botulinum toxin type A should be considered in the acute care setting for severe PVCM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988221     DOI: 10.1378/chest.118.3.874

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Paradoxical vocal cord motion disorder: past, present and future.

Authors:  Wanis H Ibrahim; Heitham A Gheriani; Ahmed A Almohamed; Tasleem Raza
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

2.  Suture lateralization of vocal cord treating paradoxical vocal cord movement: a case report.

Authors:  Orla Young; John R Russell
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-06       Impact factor: 2.503

3.  Dyspneic athlete.

Authors:  David Krey; Thomas Best
Journal:  Curr Rev Musculoskelet Med       Date:  2014-12

4.  Systematic review of the effectiveness of non-pharmacological interventions used to treat adults with inducible laryngeal obstruction.

Authors:  Jemma Haines; Jacklyn Ann Smith; James Wingfield-Digby; Jenny King; Janelle Yorke; Stephen J Fowler
Journal:  BMJ Open Respir Res       Date:  2022-06

5.  [Vocal cord dysfunction. An important differential diagnosis to bronchial asthma].

Authors:  C Kothe; G Schade; S Fleischer; M Hess
Journal:  HNO       Date:  2004-03       Impact factor: 1.284

6.  Botulinum toxin injection in laryngeal dyspnea.

Authors:  Virginie Woisard; Xuelai Liu; Marie Christine Arné Bes; Marion Simonetta-Moreau
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-06       Impact factor: 2.503

Review 7.  Severe obstructive airway disorders and diseases: vocal fold dysfunction.

Authors:  Katherine A Kendall; Samuel Louie
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

8.  Vocal cord dysfunction: a frequently forgotten entity.

Authors:  S Campainha; C Ribeiro; M Guimarães; R Lima
Journal:  Case Rep Pulmonol       Date:  2012-09-16

Review 9.  Vocal cord dysfunction: a review.

Authors:  Neha M Dunn; Rohit K Katial; Flavia C L Hoyte
Journal:  Asthma Res Pract       Date:  2015-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.